Subscribe to Newsletter

Michael Kinch

Michael Kinch is Associate Vice Chancellor and Director, Centre for Research Innovation in Business at Washington University in St Louis, US.

Content by Michael Kinch:

 Business & Regulation Business Practice

A Dangerous Trend?

| Michael Kinch

Is the reverse merger between Pfizer and Allergan the most recent chapter in a troubling trend?
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker